Budgetary Impact of Treating Acute Promyelocytic Leukemia Patients with First-Line Arsenic Trioxide and Retinoic Acid from an Italian Payer Perspective

• Morgan Kruse,

  Affiliation Optum, Cambridge, Massachusetts, United States of America

  ⨯
• Rebecca Wildner,

  Affiliation Optum, Cambridge, Massachusetts, United States of America

  ⨯
• Gisoo Barnes,

  Affiliation Teva Pharmaceuticals, Frazer, Pennsylvania, United States of America

  ⨯
• Monique Martin,

  Affiliation MapiGroup, Uxbridge, United Kingdom

  ⨯
• Udo Mueller,

  Affiliation Teva Pharmaceuticals, Ulm, Germany

  ⨯
• Francesco Lo-Coco ,

  * E-mail: francesco.lo.coco@uniroma2.it

  Affiliation Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy

  ⨯
• Ashutosh Pathak

  Affiliation Teva Pharmaceuticals, Frazer, Pennsylvania, United States of America

  ⨯